Summary
Public educational campaigns for the early diagnosis of cutaneous melanoma are considered an effective approach in the prevention of this disease, since they increase the number of cases detected early and consequently lengthen patients’ life expectancy. We performed an economic evaluation of such a campaign in Bergamo, Italy, in order to quantify its costs and consequences.
We used cost-effectiveness analysis to compare the costs and effects of the campaign with those of the ‘do nothing’ option. The analysis was performed from the perspective of the Italian National Health Service [the Servizio Sanitario Nazionale (SSN)]. Accordingly, only direct costs related to publicly financed healthcare services were considered. No indirect costs or benefits were considered because they are not relevant to the SSN. Incremental analysis was used to obtain results in terms of additional costs per life-year saved (LYS). Overall LYS were quantified by comparing the survival curves for 4 subgroups of patients with different lesional thicknesses at diagnosis (<0.76mm, 0.76 to 1.50mm, 1.51 to 3.00mm and>3.00mm). All costs were estimated in 1993 Italian lire (L).
Overall effectiveness amounted to 233.49 LYS. Using a 5% discount rate, the value of effectiveness was 171.3 LYS. The total cost of the educational campaign (i.e. the sum of the organisational and ‘induced’ costs minus the costs saved) was estimated at L817 million (approximate 1993 exchange rate $US1 = LI573), and L905 million after discounting at a rate of 5%. Thus, using discounted cost and effectiveness data, the cost of the educational campaign was L5.28 million per LYS.
Similar content being viewed by others
References
Balch CM, Houghton AN, Peters LJ. Cutaneous melanoma. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 4th ed. Philadelphia: J.B. Lippincott Co., 1993: 1612–61
McLeod GR, David NC, Little JH, et al. Melanoma in Queensland, Australia: experience in the Queensland Melanoma Project. In: Balch CM, Milton GW, editors. Cutaneous melanoma: clinical management and treatment results worldwide. Philadelphia: J.B. Lippincott Co., 1985: 379–87
Roush GC, Schymurs M, Holford TR. Risk for cutaneous melanoma in recent Connecticut birth cohorts. Am J Public Health 1985; 75: 679–82
Redman JC, Mora DB. Malignant melanomas of the skin diagnosed and treated in Albuquerque, New Mexico in 1980. J Dermatol Surg Oncol 1982; 8: 40–3
Bonett A, Roder D, Esterman A. Melanoma case survival rates in South Australia by histological type, thickness and level of tumor at diagnosis. Med J Aust 1986; 144: 680–2
Grin-Jorgensen CM, Rigel DS, Friedman RJ. The worldwide incidence of malignant melanoma. In: Balch CM, Houghton AN, Milton GW, et al., editors. Cutaneous melanoma. 2nd ed. Philadelphia: J.B. Lippincott Co., 1992: 27–39
Rigel DS, Kopf AW, Friedman RJ. The worldwide incidence of malignant melanoma in the US: are we making an impact? J Am Acad Dermatol 1987; 17: 1050–3
Johnson TM, Smith JW, Nelson BR, et al. Current therapy for cutaneous melanoma. J Am Acad Dermatol 1995; 32: 689–707
Lee JAH. The causation of melanoma. In: Balch CM, Milton GW, editors. Cutaneous melanoma: clinical management and treatment results worldwide. Philadelphia: J.B. Lippincott Co., 1985: 303–11
Armstrong BK, English DR. Epidemiologic studies. In: Balch CM, Houghton AN, Milton GW, et al., editors. Cutaneous melanoma. 2nd ed. Philadelphia: J.B. Lippincott Co., 1992: 12–26
Newell GR. Is ultraviolet irradiation the sole cause of melanoma? Melanoma Lett 1987; 5: 4
McCarthy WH, Shaw HM. Skin cancer in Australia. Med J Aust 1989; 150: 469–70
MacKie R, Hunter JAA, Altchison TC, et al. Cutaneous malignant melanoma. Lancet 1992; 339: 971–5
Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 1987
Drummond MF. Principles of economic appraisal in health care. Oxford: Oxford University Press, 1980
Garattini L. Italian health care reform. York: University of York, 1992
Cainelli T, Imberti GL, Tribbia G, et al. 1996: campagna di educazione sanitaria per la diagnosi precoce del melanoma nella provincia di Bergamo. G Ital Dermatol. In press
Bernengo MG, Doveil GC, Lisa F, et al. Melanoma cutaneo nel Centro Melanomi di Torino: sopravvivenza e correlazione con i fattori prognostici clinici ed istologici in 502 pazienti in stadio I (1975–1985). G Ital Dermatol Venereol 1986; 121(5): 311–26
GIPME (Gruppo Italiano Polidisciplinare sul Melanoma). II melanoma cutaneo: protocollo di diagnosi e terapia. Milan: GIPME, 1991
Cascinelli N, Morabito A, Bufalino R, et al. Prognosis of stage I melanoma of the skin. Int J Cancer 1980; 26: 733–9
Veronesi U, Cascinelli N. Narrow excision (1 cm margin): a safe procedure for thin cutaneous melanoma. Arch Surg 1991; 126: 438–41
Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 31: 716–21
Keeler EB, Cretin S. Discounting of life-savings and other non-monetary effects. Manag Sci 1983; 29(3): 300–6
Decreto Ministero della Sanità n. 80 del 7/11/91. Revisione del nomenclatore tariffario delle prestazioni specialistiche ambulatoriali: supplemento ordinario della Gazzetta Ufficiale della Repubblica Italiana, n. 286 del 6/12/91 — Serie Generale
Garattini L, Grilli R, Scopelliti D, et al. A proposal for Italian guidelines in pharmacoeconomics. PharmacoEconomics 1995; 7(1): 1–6
Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994; 3: 95–104
Weinstein MC, Fineberg HV, Elstein AS, et al. Clinical decision analysis. Philadelphia: WB Saunders, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Garattini, L., Cainelli, T., Tribbia, G. et al. Economic Evaluation of an Educational Campaign for Early Diagnosis of Cutaneous Melanoma. Pharmacoeconomics 9, 146–155 (1996). https://doi.org/10.2165/00019053-199609020-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199609020-00006